AZBio Board Member Dr. Steve Potts was in Washington, D.C. on Wednesday, September 20, 2023. He testified in the Subcommittee on Oversight and Investigations of the House Energy and Commerce Committee on how the Inflation Reduction Act’s price setting provisions are already raising the hurdles for health innovators as they race to develop new small molecule treatments and cures. Continue reading
Author Archive: AZBio
Cancer Caregivers of America Launches Online Cancer Caregivers Educational Platform
Comprehensive online program allows patients, caregivers, and families education, tools, and support systems specific to caring for cancer patients of all kinds.Continue reading
Ceria Therapeutics, Inc. Awarded a $2,100,000 SBIR Grant to Advance Development of a Novel Treatment for Acute Lung Injuries, Acute Lung Failure, and Acute Respiratory Distress Syndrome
The award will go towards the development of CTX-002 in preparation for clinical studiesContinue reading
Drug Discovery Summit catalyst for new approaches and therapies
Academic researchers and industry professionals will discuss drug development at the Fifth Annual Arizona Drug Discovery and Development Summit during Arizona Bioscience WeekContinue reading
Jazz Pharmaceuticals Announces Key Update to Leadership Team
Renée Galá promoted to President and Chief Operating Officer
National Institutes of Health To Locate Signature Research Program on the Phoenix Bioscience Core
PHOENIX (September 14, 2023) – Wexford Science & Technology, LLC today announced that the National Institutes of Health has signed a lease at 850 PBC and will use the space to accommodate the Phoenix Epidemiology & Clinical Research Branch of the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This innovative basic, translational, and clinical research center will occupy the entire 7th floor of 850 PBC, comprising approximately 35,000 square feet.Continue reading
Johnson & Johnson Marks New Era as Global Healthcare Company with Updated Visual Identity
Brand and visual identity demonstrate the best of Johnson & Johnson’s care and humanity, while capturing the Company’s passion and determination to improve the health of people worldwide
CDC Recommends Updated COVID-19 Vaccine for Fall/Winter Virus Season
CDC recommends everyone 6 months and older get an updated COVID-19 vaccine to protect against the potentially serious outcomes of COVID-19 illness this fall and winter. Updated COVID-19 vaccines from Pfizer-BioNTech and Moderna will be available later this week.Continue reading
Arizona Tech Investors Gears Up Its 14th Season with a Strong Lineup of Investment Opportunities
As we launch our 14th season, we are excited to continue our mission of fostering innovation, growth, and collaboration within Arizona’s tech landscape.”- Bob DeLean
Continue reading
Integrating Drug-Drug Interactions and Lifestyle Factors with Drug-Gene Interactions Provided by Castle Biosciences’ IDgenetix® Test Significantly Impacted the Number of Drug Recommendations for Patients with Moderate to Severe Depression
Integrating Drug-Drug Interactions and Lifestyle Factors with Drug-Gene Interactions Provided by Castle Biosciences’ IDgenetix® Test Significantly Impacted the Number of Drug Recommendations for Patients with Moderate to Severe DepressionContinue reading